Share
 
Title
Code
Session Type
Channel
Date Time
Co-Chairs:
Organizer:

We live in exciting times for HIV prevention technology. Yet millions of people still become HIV infected each year. New tools that expand the choices available and that give people the power to protect themselves from HIV are needed. But such tools must be conceived, developed and tested in ways that ensure that participants in clinical trials are recruited and protected within established ethical frameworks. UNAIDS and WHO have managed a year-long process to update their guidance on ethical considerations in HIV prevention trials. The guidance is relevant to the wide range of stakeholders who are committed to seeing effective HIV prevention for everyone. The satellite will be of interest to all such stakeholders including communities, researchers, sponsors, regulators, funders, ethicists, and research ethics committee members.

SA01.01 Welcome
Soumya SWAMINATHAN, WHO, Switzerland
SA01.02 Setting the scene for the new UNAIDS-WHO guidance
Peter GODFREY-FAUSSETT, UNAIDS and LSHTM, Switzerland
SA01.03 The new UNAIDS-WHO guidance – process and content
Prof. Elizabeth BUKUSI, Kenya Medical Research Institute (KEMRI), Kenya
SA01.05 Audience questions to the panel and speakers
Meg DOHERTY, WHO, Switzerland
SA01.06 Closing thoughts
Shannon HADER, UNAIDS, Switzerland